2-Benzylisoindolin-5-amine

Catalog No.: 
ACKLLV580
CAS No.: 
127168-70-1
Molecular Formula: 
C15H16N2
Molecular Weight: 
224.31
2-Benzylisoindolin-5-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$242.00InquiryInquiry
100mg95%$357.00InquiryInquiry
250mg95%$563.00InquiryInquiry
1g95%$2230.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Benzylisoindolin-5-amine
IUPAC Name2-Benzylisoindolin-5-amine
MDL No.MFCD07186379
Molecular FormulaC15H16N2
Molecular Weight224.31
SMILESNC1=CC2=C(CN(CC3=CC=CC=C3)C2)C=C1
InChI KeyAPHDKXQNTZQBHW-UHFFFAOYSA-N
Synonym2-BENZYL-2,3-DIHYDRO-1H-ISOINDOL-5-YLAMINE;ASINEX-REAG BAS 09890155;TIMTEC-BB SBB011535;2-benzylisoindolin-5-amine;B90101;[2-(benzyl)isoindolin-5-yl]amine;2-(phenylmethyl)-1,3-dihydroisoindol-5-amine;2-(phenylmethyl)-5-isoindolinamine
CAS No.127168-70-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKLLV580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACKLLV580 route product structure diagram
    ACKLLV580127168-70-1
Inquiry

2. ACKLLV580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKLLV580 route product structure diagram
    ACKLLV580127168-70-1
Inquiry

3. ACKLLV580 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKLLV580 route product structure diagram
    ACKLLV580127168-70-1
Inquiry

Comments (0)